Quick Answer
RECURSION PHARMACEUTICALS, INC. reported Total Assets of $1.47 billion for fiscal year 2025.
RECURSION PHARMACEUTICALS, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.47B | +1.8% |
| 2024 | $1.45B | +121.6% |
| 2023 | $653.70M | -6.8% |
| 2022 | $701.29M | +14.9% |
| 2021 | $610.35M | +104.4% |
| 2020 | $298.58M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.40B | +92.6% | +7.5% |
| June 30, 2025 | $1.30B | +67.9% | -0.2% |
| March 31, 2025 | $1.31B | +134.0% | -9.9% |
| December 31, 2024 | $1.45B | +121.6% | +99.4% |
| September 30, 2024 | $726.50M | +15.2% | -6.4% |
| June 30, 2024 | $775.86M | +16.4% | +39.1% |
| March 31, 2024 | $557.85M | -11.1% | -14.7% |
| December 31, 2023 | $653.70M | -6.8% | +3.6% |
- RECURSION PHARMACEUTICALS, INC. showed an increase of +1.8% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, RECURSION PHARMACEUTICALS, INC.’s total assets has grown by 393.7% (from $298.58 million to $1.47 billion).
- The most recent figure is from RECURSION PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: